Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

Summary by Science Daily
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.

1 Articles

Science DailyScience Daily
Center

Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.

·Encinitas, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Science Daily broke the news in Encinitas, United States on Saturday, August 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Ozempic icon

Ozempic

Wegovy icon

Wegovy

GLP-1 icon

GLP-1

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal